Improving patient outcomes in heart failure: evidence and barriers.
Cleland
J G
JG
Academic Unit, Department of Cardiology, University of Hull, Castle Hill Hospital, Kingston Upon Hull, HU16 5JQ, UK. j.g.cleland@medschool.ac.uk
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000191:economics / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D000075202:Contraindications; D003362:Cost-Benefit Analysis; D016330:Frail Elderly; D006333:Heart Failure / Q000401:mortality / Q000628:therapy*; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin